By Manita Rawat, Lindsay Allen and Theodore Rand ( July 15, 2026, 4:06 PM EDT) -- Behind the scenes of the 2026 FIFA World Cup, a match based on data is racking up points. It is estimated that the tournament's 104 matches will generate more than 90 petabytes of data, representing a staggering 45-fold increase over the volume produced during the 2022 games.... Law360 is on it, so you are, too.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Theodore Rand
Soccer’s Big Data Dilemma: Who Owns the Data Behind the Beautiful Game?
Behind the scenes of the 2026 FIFA World Cup, a match based in data is racking up points. It is estimated that the tournament's 104 matches will generate more than 90 petabytes of data, representing a staggering 45-fold increase over the volume produced during the 2022 games. So who owns all that data? The answer sits at the intersection of intellectual property (IP) law, contractual rights, privacy and biometric regulations, antitrust law, and emerging AI governance frameworks.
Motorola Ruling Solidifies Discretionary Authority Of USPTO
By Dion Bregman and Theodore Rand ( November 25, 2025, 4:27 PM EST) -- On Nov. 6, the U.S. Court of Appeals for the Federal Circuit's latest ruling in In re: Motorola Solutions Inc. solidifies the discretionary authority of the U.S. Patent and Trademark Office director over inter partes review institution decisions, underscores the limited scope of judicial review, and clarifies the boundaries of due process and Administrative Procedure Act claims in the context of shifting USPTO guidance....
The In re Motorola CAFC Ruling Reaffirms Discretionary, Nonappealable Nature of PTAB IPR Institution Decisions
The Federal Circuit’s latest ruling in In re Motorola Solutions, Inc. solidifies the discretionary authority of the USPTO director over inter partes review institution decisions, underscores the limited scope of judicial review, and clarifies the boundaries of due process and Administrative Procedure Act claims in the context of shifting USPTO guidance. The case arises from a series of inter partes review (IPR) proceedings initiated by Motorola Solutions, Inc.
IPR Decisions Clarify Stewart's 'Settled Expectations' Factor
By Theodore Rand, Alexander Stein and Liya Levin ( July 25, 2025, 6:00 PM EDT) -- On June 6, the U.S. Patent and Trademark Office's acting director, Coke Morgan Stewart, discretionarily denied institution of an inter partes review in iRhythm Technologies Inc. v. Welch Allyn Inc. based on a new consideration - "settled expectations," that is, the length of time that the challenged patent had been in force.... Law360 is on it, so you are, too.
IPR Decisions Clarify Stewart's 'Settled Expectations' Factor
ADVERTISEMENT Don't want ads? Subscribe or login now. By Theodore Rand, Alexander Stein and Liya Levin ( July 25, 2025, 6:00 PM EDT) -- On June 6, the U.S. Patent and Trademark Office's acting director, Coke Morgan Stewart, discretionarily denied institution of an inter partes review in iRhythm Technologies Inc. v. Welch Allyn Inc. based on a new consideration — "settled expectations," that is, the length of time that the challenged patent had been in force....
IPR Decisions Clarify Stewart's 'Settled Expectations' Factor
On June 6, the U.S. Patent and Trademark Office's acting director, Coke Morgan Stewart, discretionarily denied institution of an inter partes review in iRhythm Technologies Inc. v. Welch Allyn Inc. based on a new consideration -- "settled expectations," that is, the length of time that the challenged patent had been in force. Stewart has since issued more discretionary denial decisions that have begun to illuminate the contours of this new factor. One such decision was Dabico Airport Solutions Inc. v.
‘Settled Expectations,’ PTAB’s New Discretionary Denial Factor, Gains Additional Footing in Dabico | JD Supra
Acting Director of the USPTO Coke Morgan Stewart recently discretionarily denied institution of an inter partes review (IPR) based on a new consideration, “settled expectations,” that is, the length of time that the challenged patent had been in force. The Acting Director has since issued more discretionary denial decisions that have begun to illuminate the contours of this new factor.
‘Settled Expectations,’ PTAB’s New Discretionary Denial Factor, Gains Additional Footing in Dabico
Acting Director of the USPTO Coke Morgan Stewart recently discretionarily denied institution of an inter partes review (IPR) based on a new consideration, “settled expectations,” that is, the length of time that the challenged patent had been in force. The Acting Director has since issued more discretionary denial decisions that have begun to illuminate the contours of this new factor.
Meet the New Discretionary Denial Factor on the PTAB Block: Settled Expectations | JD Supra
USPTO Acting Director Coke Morgan Stewart recently issued a decision discretionarily denying five petitions for inter partes review (IPR) filed by iRhythm against patents owned by Welch Allyn based on a factor that had not been used before—the petitioner’s longstanding awareness of an issued patent.
Meet the New Discretionary Denial Factor on the PTAB Block: Settled Expectations
USPTO Acting Director Coke Morgan Stewart recently issued a decision discretionarily denying five petitions for inter partes review (IPR) filed by iRhythm against patents owned by Welch Allyn based on a factor that had not been used before—the petitioner’s longstanding awareness of an issued patent.
Federal Circuit Clarifies Scope and Timing of Collateral Estoppel for Claims Under IPR | JD Supra
In a recent opinion, the Federal Circuit added several new wrinkles to amendment practice in inter partesreview proceedings. The court affirmed the Patent Trial and Appeal Board’s determination that most of the original claims challenged by an IPR were unpatentable as obvious, and reversed the Board’s determination as to the sole surviving claim, concluding that it too was unpatentable as obvious.
Federal Circuit Clarifies Scope and Timing of Collateral Estoppel for Claims Under IPR
In a recent opinion, the Federal Circuit added several new wrinkles to amendment practice in inter partesreview proceedings. The court affirmed the Patent Trial and Appeal Board’s determination that most of the original claims challenged by an IPR were unpatentable as obvious, and reversed the Board’s determination as to the sole surviving claim, concluding that it too was unpatentable as obvious.
A Look at Key USPTO Director Review Decisions and their Significance
“Looking at the Director Review (DR) decisions so far in 2024, preliminary observations show that the landscape around the DR process appears to be shifting from sua-sponte focused DRs to party-initiated DRs.” Prior to the Supreme Court’s 2021 decision in United States v. Arthrex, Inc., while there were some mechanisms for review of decisions by Patent Trial and Appeal Board (PTAB) panels, Director Review (DR) as a standalone review mechanism was essentially non-existent.
A Look at Key USPTO Director Review Decisions and their Significance, IPWatchdog
Prior to the Supreme Court’s 2021 decision in United States v. Arthrex, Inc., while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. After Arthrex, however, that changed—with the US Patent and Trademark Office setting forth an interim DR process, followed by a revised DR process, and now formal rulemaking in April 2024.
USPTO Revises Interim Director Review Process, Gives Guidance on Ex Parte Appeals, and Forms New Review Panels | JD Supra
The US Patent and Trademark Office (USPTO) recently issued an update to its procedures for interim Director Review (DR) of decisions by the Patent Trial and Appeal Board (PTAB), evidencing USPTO Director Kathi Vidal’s efforts to formalize the process and procedures for conducting DRs following the US Supreme Court’s Arthrex decision. The July 24, 2023 update further revises the interim DR process published on June 29, 2021 (and subsequently updated in April, May, and June 2022).
USPTO Revises Interim Director Review Process, Gives Guidance on Ex Parte Appeals, and Forms New Review Panels
The US Patent and Trademark Office (USPTO) recently issued an update to its procedures for interim Director Review (DR) of decisions by the Patent Trial and Appeal Board (PTAB), evidencing USPTO Director Kathi Vidal’s efforts to formalize the process and procedures for conducting DRs following the US Supreme Court’s Arthrex decision. The July 24, 2023 update further revises the interim DR process published on June 29, 2021 (and subsequently updated in April, May, and June 2022).
Common threads in public comments to the USPTO’s PTAB reform proposals
Common threads in public comments to the USPTO’s PTAB reform proposals Many stakeholders are scratching their heads over whether the patent office has authority to make the changes for which it has sought feedback Register to receive our newsletter and gain limited access to subscriber content. Register now Get news, unique commentary, expert analysis and essential resources from the IAM experts. Subscribe now
USPTO Unleashes Wave of PTAB Rule Proposals | JD Supra
The US Patent and Trademark Office (USPTO) published an Advance Notice of Proposed Rulemaking (ANPRM) on April 20 seeking comments on proposed changes to America Invents Act trial proceedings before the Patent Trial and Appeal Board (PTAB). The ANPRM includes a wide range of proposals relating to rules the USPTO director will use in exercising discretion to institute post-grant review proceedings, including discretionary denials under 35 USC 314(a), 324(a), and 325(d).
Federal Circuit Clarifies IPR Estoppel Burden | JD Supra
A recent Federal Circuit opinion clarified that patent owners carry the burden of proving that inter partes review (IPR) estoppel applies to invalidity grounds not included in their IPR petitions. The Federal Circuit also endorsed—for the first time—the “skilled searcher” standard often used by district courts in determining whether a nonpetitioned ground could have reasonably been raised at the PTAB pursuant to 35 USC § 315(e). In Ironburg Inventions Ltd. v.
USPTO Unleashes Wave of PTAB Rule Proposals
The US Patent and Trademark Office (USPTO) published an Advance Notice of Proposed Rulemaking (ANPRM) on April 20 seeking comments on proposed changes to America Invents Act trial proceedings before the Patent Trial and Appeal Board (PTAB). The ANPRM includes a wide range of proposals relating to rules the USPTO director will use in exercising discretion to institute post-grant review proceedings, including discretionary denials under 35 USC 314(a), 324(a), and 325(d).
Federal Circuit Clarifies IPR Estoppel Burden
A recent Federal Circuit opinion clarified that patent owners carry the burden of proving that inter partes review (IPR) estoppel applies to invalidity grounds not included in their IPR petitions. The Federal Circuit also endorsed—for the first time—the “skilled searcher” standard often used by district courts in determining whether a nonpetitioned ground could have reasonably been raised at the PTAB pursuant to 35 USC § 315(e). In Ironburg Inventions Ltd. v.
USPTO Unleashes Wave of PTAB Rule Proposals
The US Patent and Trademark Office (USPTO) published an Advance Notice of Proposed Rulemaking (ANPRM) on April 20 seeking comments on proposed changes to America Invents Act trial proceedings before the Patent Trial and Appeal Board (PTAB). The ANPRM includes a wide range of proposals relating to rules the USPTO director will use in exercising discretion to institute post-grant review proceedings, including discretionary denials under 35 USC 314(a), 324(a), and 325(d).
USPTO Director Designates Precedential Decision on Conclusory Expert Declarations | JD Supra
Director of the US Patent and Trademark Office (USPTO) Kathi Vidal recently designated as precedential a decision by the Patent Trial and Appeal Board (PTAB) rejecting the petitioner’s invalidity challenge, since it was based entirely on a conclusory expert witness declaration.
USPTO Director Designates Precedential Decision on Conclusory Expert Declarations
Director of the US Patent and Trademark Office (USPTO) Kathi Vidal recently designated as precedential a decision by the Patent Trial and Appeal Board (PTAB) rejecting the petitioner’s invalidity challenge, since it was based entirely on a conclusory expert witness declaration.
USPTO Director Designates Precedential Decision on Conclusory Expert Declarations
Director of the US Patent and Trademark Office (USPTO) Kathi Vidal recently designated as precedential a decision by the Patent Trial and Appeal Board (PTAB) rejecting the petitioner’s invalidity challenge, since it was based entirely on a conclusory expert witness declaration.
PTAB Considers Interim Fintiv Guidance in Refusing to Exercise Discretion to Deny Institution | JD Supra
The Patent Trial and Appeal Board recently granted the institution of an inter partes review in Samsung Electronics Co. v. Staton Techiya, LLC, despite the existence of a parallel proceeding in the US District Court for the Eastern District of Texas.
PTAB Emphasizes Expert Availability and Clarifies Fintiv Inquiry for Prior District Court Cases | JD Supra
The US Patent Trial and Appeal Board on December 23, 2021, instituted an inter partes review even though an unrelated party had already unsuccessfully challenged the validity of the patent in district court. In the decision granting institution, the board found unpersuasive arguments that the case should be discretionarily denied based on declarations of experts who were not presently engaged in the proceeding and a prior unsuccessful invalidity challenge in the other litigation.
Alice in 2020: Slashing Software Patents and Searching for Functional Language at the Federal Circuit (Part II)
“It is not particularly clear what passes muster under Alice when it comes to software claims, but lines are emerging in the sand as to what the court is looking for.” In Part I of this article, I explained that the CAFC invalidated almost every software patent on appeal for eligibility in 2020 and recapped the first 13 such cases of the year. Despite the many software eligibility cases decided last year, there is still some uncertainty about what passes muster under the Alice two-step framework.
Alice in 2020: Slashing Software Patents and Searching for Functional Language at the Federal Circuit (Part I)
“In 2020, there were 27 software-related patents on appeal for subject matter eligibility. The CAFC found four of the patents either partially or fully eligible under Section 101. It found 22 patents invalid and remanded one case to the district court.” Last year was an active one at the United States Court of Appeals for the Federal Circuit (CAFC) for software eligibility. It also was a brutal year for patent owners, as the CAFC invalidated almost every software patent on appeal for eligibility.
CAFC Affirms Prosecution History Estoppel Does Not Bar Eli Lilly from Asserting Infringement Under the Doctrine of Equivalents
By Theodore Rand December 29, 2020 “While it is refreshing to see a pro-patentee outcome at the Federal Circuit, the court’s reasoning as to [indefiniteness under Section 112] seems to contradict the purpose of the MPEP’s prohibition against trade names as descriptors of substances and materials.” In Eli Lilly & Co. v. Apotex, Inc., decided last week, the Federal Circuit affirmed a district court finding of infringement under the doctrine of equivalents.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Theodore
Contact Theodore, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack